Skip to main content
Equibles
BRKR logo

BRKR · Bruker Corp · Metrics

Track BRKR — free

Use BRKR with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research BRKR.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$60.74 +2.51 (+4.31%) At close · Oct 27 Q2 2026 earnings call transcript
S&P 400 member Russell 1000 member Rebalance outlook locked
Market Cap
$9.42B
Shares
155.12M
Volume · Oct 27 2.38M Avg daily vol (3M) 2.3M

BRKR metrics

108 of 122 screener metrics currently available.

Open in screener

Market overview

2 metrics
Share price
$60.74
Market cap
$9.42B

Price action

20 metrics
Price change (1W)
+5.2%
Price change (30D)
-8.0%
Price change (3M)
-3.0%
Price change (6M)
+59.4%
Price change (YTD)
+23.6%
Price change (1Y)
+49.3%
Trailing year
Price change (5Y)
-26.6%
52-week high
$64.75
52-week low
$32.76
Change from 52-week high
-10.1%
Change from 52-week low
+77.7%
Annualized volatility
56.5%
Annualized volatility (3M)
67.1%
Beta
1.4
RSI (14D)
49.6
Price vs SMA 50
-0.8%
Price vs SMA 200
+16.3%
Avg volume (3M)
2.29M
Relative volume
1.0
Average dollar volume
$133.56M

Company

3 metrics
Sector
Healthcare
Industry
Medical Devices
Shares outstanding
155.12M

Valuation

12 metrics
P / E (TTM)
—
Trailing earnings
PEG ratio
—
EV / revenue
3.0×
reciprocal yield 32.8%
EV / EBITDA
53.5×
reciprocal yield 1.9%
EV / EBIT
—
P / sales
2.6×
reciprocal yield 38.7%
P / book
3.8
reciprocal yield 26.6%
FCF yield
1.0%
TTM · current market cap
Buyback yield
0.0%
P / FCF
96.2
reciprocal yield 1.0%
P / operating cash flow
47.4
reciprocal yield 2.1%
Earnings yield
-0.8%

Historical valuation

8 metrics
P / E historical average (3Y)
37.5×
reciprocal yield 2.7%
P / E historical average (5Y)
40.7×
reciprocal yield 2.5%
EV / revenue historical average (3Y)
3.0×
reciprocal yield 33.3%
EV / revenue historical average (5Y)
3.6×
reciprocal yield 28.1%
EV / EBIT historical average (3Y)
55.4×
reciprocal yield 1.8%
EV / EBIT historical average (5Y)
44.7×
reciprocal yield 2.2%
EV / EBITDA historical average (3Y)
25.0×
reciprocal yield 4.0%
EV / EBITDA historical average (5Y)
24.0×
reciprocal yield 4.2%

Dividends & buybacks

7 metrics
Dividend yield
0.3%
Trailing 12 months
Payout ratio
—
Shareholder yield
—
Dividend / share (TTM)
$0.20
Dividend growth YoY
+0.0%
Dividend growth streak
0
Last ex-dividend
2026-09-21

Earnings calendar

2 metrics
Next earnings
2026-11-04
Last earnings
2026-08-04

Profitability

9 metrics
Gross margin
46.4%
Operating margin
-0.9%
Trailing 12 months
Net margin
-2.0%
Gross profit (TTM)
$1.62B
Operating profit (TTM)
−$30.60M
Net income (TTM)
−$71.20M
Trailing 12 months
Diluted EPS (TTM)
$-0.70
FCF margin
2.7%
Effective tax rate
—

Per share

11 metrics
Revenue per diluted share (TTM)
$23.00
Gross profit per diluted share (TTM)
$10.68
Operating profit per diluted share (TTM)
$-0.20
EBITDA per diluted share (TTM)
$1.31
Net income per diluted share (TTM)
$-0.47
Operating cash flow per diluted share (TTM)
$1.25
Free cash flow per diluted share (TTM)
$0.62
Capital expenditures per diluted share (TTM)
$0.63
R&D per diluted share (TTM)
$2.59
Stock compensation per diluted share (TTM)
—
Book value per share
$15.75

Growth

11 metrics
Revenue growth YoY
+5.2%
Year over year
Net income growth YoY
-784.2%
Revenue (TTM)
$3.50B
Trailing 12 months
EPS growth YoY
-920.0%
Shares change YoY
+0.4%
Year over year · more shares
Revenue CAGR (3Y)
+10.7%
Revenue CAGR (5Y)
+11.6%
EPS CAGR (3Y)
—
EPS CAGR (5Y)
—
FCF CAGR (3Y)
-33.2%
FCF CAGR (5Y)
-28.7%

Quality

14 metrics
Return on equity
-3.0%
Return on assets
-1.2%
Debt / equity
0.8
Current ratio
1.8
EBITDA (TTM)
$199.50M
Free cash flow (TTM)
$93.90M
Quick ratio
0.9
Interest coverage
-0.5
Net debt / EBITDA
8.2
Return on invested capital
—
Trailing 12 months
Net cash
−$1.64B
Latest balance sheet
Cash & equivalents
$184.90M
Total assets
$6.05B
Total debt
$1.82B

Cash flow & spend

7 metrics
Operating cash flow (TTM)
$190.40M
Capital expenditures (TTM)
$96.50M
R&D (TTM)
$393.50M
SG&A (TTM)
$970.70M
Stock compensation (TTM)
$25.30M
R&D / revenue
11.2%
Stock compensation / revenue
—

Ownership (13F)

9 metrics
13F filers
434
13F filer change QoQ
+71
Institutional ownership
94.2%
Conviction holders (share of 13F filers)
1.7%
Crowding (high-turnover and private-fund holders)
—
Private-fund adviser ownership
—
Active holders' share change QoQ
+3.6%
Holder tenure
14.8
Price vs estimated holder cost
+41.1%

Ownership (registered funds)

1 metrics
Index-fund ownership
16.1%

Short interest

3 metrics
Short interest
8.2%
Latest settlement · 5.7 days to cover
Days to cover
5.7d
Short-squeeze score
70 / 100

Insider activity

2 metrics
Net insider buying (90D)
−$418,554
Insider-sentiment score
39 / 100

Risk flags

1 metrics
Going concern
—
Key facts CIK 1109354 CUSIP 116794108 13F (30d) 75 filings 72 filers Visit website Investor relations